Published in Curr Opin Endocrinol Diabetes Obes on October 01, 2010
BRCA1-Dependent Translational Regulation in Breast Cancer Cells. PLoS One (2013) 1.11
Lipid abnormalities and cardiometabolic risk in patients with overt and subclinical thyroid disease. J Lipids (2011) 0.97
Responsiveness to thyroid hormone and to ambient temperature underlies differences between brown adipose tissue and skeletal muscle thermogenesis in a mouse model of diet-induced obesity. Endocrinology (2011) 0.92
Insights into eyestalk ablation mechanism to induce ovarian maturation in the black tiger shrimp. PLoS One (2011) 0.91
A histone deacetylase inhibitor improves hypothyroidism caused by a TRα1 mutant. Hum Mol Genet (2013) 0.81
NCoR1 regulates thyroid hormone receptor isoform-dependent adipogenesis. J Mol Endocrinol (2011) 0.80
Thyroid hormone analogues for the treatment of metabolic disorders: new potential for unmet clinical needs? Endocr Pract (2012) 0.77
Low Urinary Iodine Concentrations Associated with Dyslipidemia in US Adults. Nutrients (2016) 0.77
Prenatal Exposures to Multiple Thyroid Hormone Disruptors: Effects on Glucose and Lipid Metabolism. J Thyroid Res (2016) 0.76
New insights into thyroid hormone actions and lipid metabolism. Curr Opin Endocrinol Diabetes Obes (2010) 0.76
Long Noncoding RNA and mRNA Expression Profiles in the Thyroid Gland of Two Phenotypically Extreme Pig Breeds Using Ribo-Zero RNA Sequencing. Genes (Basel) (2016) 0.75
Inherent suppression of thyroid stimulating hormone in newly diagnosed dyslipidemic patients - indication for use of thyromimetics? J Clin Diagn Res (2014) 0.75
Both 3,5-Diiodo-L-Thyronine and 3,5,3'-Triiodo-L-Thyronine Prevent Short-term Hepatic Lipid Accumulation via Distinct Mechanisms in Rats Being Fed a High-Fat Diet. Front Physiol (2017) 0.75
The nuclear receptor superfamily: the second decade. Cell (1995) 24.99
An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell (1975) 8.29
Deconstructing repression: evolving models of co-repressor action. Nat Rev Genet (2010) 3.29
Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation. Mol Cell (2007) 3.18
Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia. N Engl J Med (2010) 3.17
Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone. Proc Natl Acad Sci U S A (2000) 2.49
Characterization of seven novel mutations of the c-erbA beta gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two "hot spot" regions of the ligand binding domain. J Clin Invest (1991) 2.40
Multiple mechanisms for regulation of the transcriptional activity of thyroid hormone receptors. Rev Endocr Metab Disord (2000) 1.71
Thyroid hormone receptors: lessons from knockout and knock-in mutant mice. Trends Endocrinol Metab (2003) 1.69
Intracellular conversion of thyroxine to triiodothyronine is required for the optimal thermogenic function of brown adipose tissue. J Clin Invest (1987) 1.67
Functions of thyroid hormone receptors in mice. Thyroid (2000) 1.61
Thyroid hormone induced brown adipose tissue and amelioration of diabetes in a patient with extreme insulin resistance. J Clin Endocrinol Metab (2009) 1.59
Depressed thermogenesis but competent brown adipose tissue recruitment in mice devoid of all hormone-binding thyroid hormone receptors. Mol Endocrinol (2003) 1.58
Thyroid hormone--sympathetic interaction and adaptive thermogenesis are thyroid hormone receptor isoform--specific. J Clin Invest (2001) 1.54
Thyroid hormone-related regulation of gene expression in human fatty liver. J Clin Endocrinol Metab (2009) 1.44
A targeted dominant negative mutation of the thyroid hormone alpha 1 receptor causes increased mortality, infertility, and dwarfism in mice. Proc Natl Acad Sci U S A (2001) 1.42
A thyroid hormone receptor alpha gene mutation (P398H) is associated with visceral adiposity and impaired catecholamine-stimulated lipolysis in mice. J Biol Chem (2003) 1.36
Hypermetabolism in mice caused by the central action of an unliganded thyroid hormone receptor alpha1. EMBO J (2007) 1.33
Requirement for thyroid hormone receptor beta in T3 regulation of cholesterol metabolism in mice. Mol Endocrinol (2002) 1.32
Patterns of liver gene expression governed by TRbeta. Mol Endocrinol (2002) 1.31
Resistance to thyroid hormone is associated with raised energy expenditure, muscle mitochondrial uncoupling, and hyperphagia. J Clin Invest (2010) 1.27
Impaired adipogenesis caused by a mutated thyroid hormone alpha1 receptor. Mol Cell Biol (2007) 1.23
Retardation of post-natal development caused by a negatively acting thyroid hormone receptor alpha1. EMBO J (2002) 1.16
Optimal response of key enzymes and uncoupling protein to cold in BAT depends on local T3 generation. Am J Physiol (1987) 1.08
Changes in carnitine palmitoyltransferase-I mRNA abundance produced by hyperthyroidism and hypothyroidism parallel changes in activity. Biochem Biophys Res Commun (1994) 1.06
Expression of uncoupling protein 1 in mouse brown adipose tissue is thyroid hormone receptor-beta isoform specific and required for adaptive thermogenesis. Endocrinology (2009) 1.06
A thyroid hormone response unit formed between the promoter and first intron of the carnitine palmitoyltransferase-Ialpha gene mediates the liver-specific induction by thyroid hormone. J Biol Chem (2002) 1.04
Distinct dysregulation of lipid metabolism by unliganded thyroid hormone receptor isoforms. Mol Endocrinol (2009) 1.04
Effects of thyroid hormone on norepinephrine signaling in brown adipose tissue. I. Beta 1- and beta 2-adrenergic receptors and cyclic adenosine 3',5'-monophosphate generation. Endocrinology (1995) 1.03
A TRbeta-selective agonist confers resistance to diet-induced obesity. J Endocrinol (2009) 1.01
Temperature homeostasis in transgenic mice lacking thyroid hormone receptor-alpha gene products. Endocrinology (2005) 0.99
Adipogenesis is differentially impaired by thyroid hormone receptor mutant isoforms. J Mol Endocrinol (2010) 0.97
Increased adipogenesis in bone marrow but decreased bone mineral density in mice devoid of thyroid hormone receptors. Bone (2005) 0.96
Pituitary homeobox 2 (PITX2) promotes thyroid carcinogenesis by activation of cyclin D2. Cell Cycle (2010) 2.29
Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone beta receptor. Proc Natl Acad Sci U S A (2006) 1.62
Expression of mutant thyroid hormone nuclear receptors is associated with human renal clear cell carcinoma. Carcinogenesis (2002) 1.18
Contrasting skeletal phenotypes in mice with an identical mutation targeted to thyroid hormone receptor alpha1 or beta. Mol Endocrinol (2005) 1.12
Expression of uncoupling protein 1 in mouse brown adipose tissue is thyroid hormone receptor-beta isoform specific and required for adaptive thermogenesis. Endocrinology (2009) 1.06
Resistance to thyroid hormone is modulated in vivo by the nuclear receptor corepressor (NCOR1). Proc Natl Acad Sci U S A (2011) 1.00
SKI-606, an Src inhibitor, reduces tumor growth, invasion, and distant metastasis in a mouse model of thyroid cancer. Clin Cancer Res (2012) 0.99
Thyroid hormone receptors and cancer. Biochim Biophys Acta (2012) 0.99
Nuclear receptor corepressor is a novel regulator of phosphatidylinositol 3-kinase signaling. Mol Cell Biol (2007) 0.99
Knock-in mouse model for resistance to thyroid hormone (RTH): an RTH mutation in the thyroid hormone receptor beta gene disrupts cochlear morphogenesis. J Assoc Res Otolaryngol (2002) 0.99
The pituitary tumor-transforming gene promotes angiogenesis in a mouse model of follicular thyroid cancer. Carcinogenesis (2006) 0.97
Novel non-genomic signaling of thyroid hormone receptors in thyroid carcinogenesis. Mol Cell Endocrinol (2009) 0.96
Diet-induced obesity increases tumor growth and promotes anaplastic change in thyroid cancer in a mouse model. Endocrinology (2013) 0.92
Role of TSH in the spontaneous development of asymmetrical thyroid carcinoma in mice with a targeted mutation in a single allele of the thyroid hormone-β receptor. Endocrinology (2012) 0.92
Hyperactivity, impaired learning on a vigilance task, and a differential response to methylphenidate in the TRbetaPV knock-in mouse. Psychopharmacology (Berl) (2005) 0.91
Multi-tissue gene-expression analysis in a mouse model of thyroid hormone resistance. Genome Biol (2004) 0.90
Tumor suppressor action of liganded thyroid hormone receptor beta by direct repression of beta-catenin gene expression. Endocrinology (2010) 0.90
Differential recruitment of nuclear coregulators directs the isoform-dependent action of mutant thyroid hormone receptors. Mol Endocrinol (2011) 0.88
Characterization of skeletal phenotypes of TRalpha1 and TRbeta mutant mice: implications for tissue thyroid status and T3 target gene expression. Nucl Recept Signal (2006) 0.87
Novel functions of thyroid hormone receptor mutants: beyond nucleus-initiated transcription. Steroids (2006) 0.86
Novel oncogenic actions of TRbeta mutants in tumorigenesis. IUBMB Life (2009) 0.86
Regulation of fibroblast growth factor receptor-1 (FGFR1) by thyroid hormone: identification of a thyroid hormone response element in the murine Fgfr1 promoter. Endocrinology (2007) 0.84
Gelsolin: a novel thyroid hormone receptor-beta interacting protein that modulates tumor progression in a mouse model of follicular thyroid cancer. Endocrinology (2006) 0.83
Inhibition of tumorigenesis by the thyroid hormone receptor β in xenograft models. Thyroid (2013) 0.82
Advanced bone formation in mice with a dominant-negative mutation in the thyroid hormone receptor β gene due to activation of Wnt/β-catenin protein signaling. J Biol Chem (2012) 0.82
A histone deacetylase inhibitor improves hypothyroidism caused by a TRα1 mutant. Hum Mol Genet (2013) 0.81
Complex temporal changes in TGFβ oncogenic signaling drive thyroid carcinogenesis in a mouse model. Carcinogenesis (2013) 0.81
Thyroid hormone receptor α mutation causes a severe and thyroxine-resistant skeletal dysplasia in female mice. Endocrinology (2014) 0.79
The cytoplasmic domain of proEGF negatively regulates motility and elastinolytic activity in thyroid carcinoma cells. Neoplasia (2008) 0.79
Three-dimensional telomere dynamics in follicular thyroid cancer. Thyroid (2013) 0.78
Expression of stanniocalcin 1 in thyroid side population cells and thyroid cancer cells. Thyroid (2015) 0.76
Update in thyroidology 2010. J Clin Endocrinol Metab (2011) 0.75